John Abramic Image

John Abramic

John Abramic is a partner at Steptoe & Johnson. He is an experienced patent litigator who represents clients in complex intellectual property disputes and serves as lead counsel in federal district courts and arbitrations throughout the United States. While John is often recognized for his experience with disputes in the pharmaceutical and medical device industries, including Hatch-Waxman litigation, he has litigated matters across a variety of technical fields, including chemicals, electronics, semiconductors, telecommunications, machinery, and computer software.

For more information or to contact John, visit his Firm Profile Page.

Recent Articles by John Abramic

Top Five Takeaways From a Deep Dive Into Obviousness at the PTAB

Since the America Invents Act ushered in a series of sweeping changes to the U.S. patent system in 2011, IP stakeholders have been grappling with Inter Partes Review proceedings (IPRs) before the Patent Trial and Appeal Board (PTAB). More than 8,000 IPR petitions have been filed since 2012. IPRs differ from court proceedings in many ways, including more restricted discovery, tighter deadlines, and particular rules and procedures for the submission of arguments and evidence. Despite these differences, the substantive law underlying the patent challenges is the same for IPRs and court proceedings. In an IPR, a Petitioner is allowed to challenge a patent’s validity under the doctrines of anticipation or obviousness. These same challenges are available in court, and the substantive law for anticipation and obviousness is theoretically supposed to be the same for IPRs or for court proceedings. Given that the substantive doctrines of anticipation and obviousness have existed and have been refined for more than a century, and that these doctrines are the same for PTAB and federal court proceedings, practitioners have tended to focus more on the doctrines, rules and procedures specific to IPRs when publishing on IPR practice. An in-depth study of obviousness in IPRs, however, reveals significant differences in the way the PTAB analyzes obviousness as compared to the courts and issues where the PTAB’s approach has changed over time. Over 90% of final written decisions in IPRs in the last three years have included obviousness grounds (as compared to less than 30% for anticipation). The doctrine of obviousness includes a multi-factor test, each factor including numerous sub-doctrines that can impact the analysis. Understanding precisely how the PTAB is analyzing and treating obviousness can improve a litigant’s chances of success in an IPR, whether as a patent owner or a patent challenger.